Data is not available at this time.
Morpho, Inc. is a specialized technology firm focused on AI-driven image and video processing solutions, serving diverse industries such as smart devices, automotive, semiconductors, and digital media. The company generates revenue primarily through licensing its proprietary algorithms and software packages, which include advanced features like image stabilization, noise reduction, HDR generation, and AI-based segmentation. Its products cater to both hardware manufacturers and software developers, positioning Morpho as a critical enabler of next-generation visual technologies. Operating globally with a presence in Japan, the U.S., China, and Europe, the company competes in the high-growth AI and computer vision markets, where demand for real-time processing and enhanced imaging capabilities is expanding rapidly. Morpho’s niche expertise in edge AI and lightweight inference engines gives it an edge in embedded systems and mobile applications, though it faces competition from larger players with broader R&D budgets. Its focus on licensable, modular solutions allows for scalable adoption across industries, reinforcing its role as a behind-the-scenes innovator in visual technology.
Morpho reported revenue of ¥3.30 billion for FY2024, with net income of ¥301 million, reflecting a net margin of approximately 9.1%. The company’s diluted EPS stood at ¥58.76, supported by disciplined cost management. Operating cash flow was ¥207 million, though capital expenditures were minimal at -¥12.5 million, indicating a capital-light business model reliant on intellectual property rather than heavy infrastructure investment.
The company’s earnings are driven by high-margin licensing fees, with no debt on its balance sheet underscoring efficient capital allocation. Its cash position of ¥2.94 billion provides flexibility for R&D or strategic acquisitions. However, the absence of dividends suggests reinvestment priorities, aligning with its growth-focused strategy in AI and imaging technologies.
Morpho maintains a robust balance sheet with ¥2.94 billion in cash and equivalents and zero debt, reflecting strong liquidity. The lack of leverage and consistent positive cash flow indicate low financial risk, though the company’s modest scale in a competitive sector warrants monitoring of R&D ROI and market expansion costs.
Growth is likely tied to adoption of its AI solutions in emerging applications like automotive ADAS and smartphone imaging. The company does not pay dividends, prioritizing reinvestment in technology development. Its beta of 0.45 suggests lower volatility relative to the market, possibly due to its niche focus and stable licensing revenue streams.
At a market cap of ¥5.83 billion, Morpho trades at a P/E of ~19.3x based on FY2024 earnings. The valuation reflects expectations for sustained demand in AI-powered imaging, though competition and reliance on licensing cycles could introduce variability. The stock’s low beta may appeal to investors seeking tech exposure with reduced volatility.
Morpho’s strengths lie in its IP portfolio and cross-industry applicability of its imaging technologies. Challenges include scaling against larger AI rivals and maintaining innovation pace. The outlook hinges on expanding its licensee base and penetrating new verticals like medical imaging, where its noise reduction and super-resolution tools could gain traction.
Company description, financials, and market data sourced from publicly disclosed filings and exchange data.
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |